Abstract: The proposed technology enables new levels of privacy while using electronics in open or public settings via the modification and censorship of a device's displayed content in response to the presence of spectators within a visible range of content displayed. In an open or public environment, users of electronic devices with any form of display can have their privacy and security compromised by any unauthorized spectators within the aforementioned visible range. To combat this problem, the proposed technology monitors the presence of users and spectators within predetermined regions and changes the content displayed appropriately such that the spectators are deterred or prevented from viewing the user's (or users) content. The system provides an added layer of security which is advantageous to users who prefer to use their devices in public locations but are afraid of being visually hacked.

Abstract: A barrier apparatus for protecting a bus driver including a vertically-oriented panel selectively moveable along a set of tracks between a forward position and a rearward position within a bus, the forward position including the panel positioned between a driver's seat and a passenger entryway of the bus. The panel is arranged so that, when in the forward position or the rearward position or moved between the forward position and the rearward position, the panel remains on a driver's side of the bus thus ensuring that the panel does not obstruct passenger traffic into and out of the bus during any phase of operation of the barrier system.

Abstract: Described are smoking cessation devices and kits for determining an advantageous time for a subject to quit smoking, and/or for extending the duration of smoking abstinence, based on serum levels of anti-nicotine antibodies. Related methods are also described.

Abstract: Novel hapten-carrier conjugates are capable of inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in its native (S)-(?) state, and have good stability properties. The conjugates are useful in formulating vaccines for active immunization, that are used to prevent and treat nicotine addiction. The antibodies raised in response to the nicotine hapten-carrier conjugate are used for passive immunization. These antibodies are administered for prevention and treatment of nicotine addiction.

Abstract: Novel hapten-carrier conjugates are capable of inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in its native (S)-(?) state, and have good stability properties. The conjugates are useful in formulating vaccines for active immunization, that are used to prevent and treat nicotine addiction. The antibodies raised in response to the nicotine hapten-carrier conjugate are used for passive immunization. These antibodies are administered for prevention and treatment of nicotine addiction.

Abstract: The present invention relates methods for reducing the adverse effects of nicotine. This application describes the use of nicotine carrier conjugates in decreasing the toxic effects of nicotine on a fetus.

Abstract: A negatively-charged Staphylococcus antigen contains amino acids and a N-acetylated hexosamine as a major carbohydrate component. The antigen is common to many coagulase-negative strains of Staphylococcus, including S. epidermidis, S. haemolyticus, and S. hominis. Staphylococcus strains that carry the antigen include many clinically significant strains of Staphylococcus. The antigen and antibodies to the antigen are useful in kits and assays for diagnosing Staphylococcus infection. Vaccines of the antigen and of whole cells that carry the antigen also are disclosed.

Abstract: Staphylococcal and Enterrococcal glycoconjugate vaccines are disclosed for use in preventing or treating bacterial infection in an immune-compromised individual. Such vaccines contain an immunocarrier and a conjugate of a polysaccharide or glycopeptide surface antigen from a clinically-significant bacterial strain. The vaccines can be used for active protection in immune-compromised individuals who are to be subjected to conditions that place them at immediate risk of developing a bacterial infection, as would be case in the context of a catheterization or a surgical procedure.

Abstract: A high yielding and short process for preparing the 3?-aminomethylnicotine hapten of general formula I permits the isolation of the hapten in very pure quantities. The process can be adapted for the synthesis of a single stereoisomer or mixtures of stereoisomers, such as the stereoisomers trans-Ia and trans-Ib: Compounds of general formula I are useful for the preparation of hapten-carrier conjugates in the treatment of nicotine addiction.

Abstract: A method of preventing or treating staphylococcal bacterial infection in an individual is disclosed. A vaccine based on a conjugate of PS1 polysaccharide antigen can be used for active protection in individuals who are to be subjected to conditions that place them at immediate risk of developing a bacterial infection, as would be case in the context of a catheterization or a surgical procedure. Alternatively, antibodies raised in response to the antigen can be used to treat or to provide passive protection to individuals. The method can be used in a population of patients at risk for infection by various species of Staphylococcus or various types of Staphylococcus epidermidis.

Abstract: A majority of E. faecalis and E. faecium clinical isolates fall into two groups and three groups, respectively. Distinct antigens are associate with each of the five groups. The Enterococcus antigens are readily obtained from strains of E. faecalis and E. faecium, and can elicit production of protective antibodies. Accordingly, the antigens are useful for vaccines which protect against infection by clinically significant (pathogenic) Enterococcus isolates. The antigens and antibodies generated to the antigens are also useful in diagnostic assays.

Abstract: Novel hapten-carrier conjugates are capable of inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in its native (S)-(?) state, and have good stability properties. The conjugates are useful in formulating vaccines for active immunization, that are used to prevent and treat nicotine addiction. The antibodies raised in response to the nicotine hapten-carrier conjugate are used for passive immunization. These antibodies are administered for prevention and treatment of nicotine addiction.

Abstract: A method of preventing or treating staphylococcal bacterial infection in an individual is disclosed. A vaccine based on a conjugate the 336 polysaccharide antigen can be used for active protection in individuals who are to be subjected to conditions that place them at immediate risk of developing a bacterial infection, as would be case in the context of a catheterization or a surgical procedure. Alternatively, antibodies raised in response to the antigen can be used to treat or to provide passive protection to individuals. The method can be used in a population of patients at risk for infection by various species of Staphylococcus or various types of Staphylococcus aureus.

Abstract: A vehicle frame includes a load carrying framework and a body mounted on the framework. The framework has a board frame, a window frame for windscreen, a pair of upper balks and a pair of upper window balks along both sides of the vehicle and supported at least by door pillars. The window frame has a one piece U shaped member arranged between the board frame and the pair of upper balks, and an upper cross member connected to prongs of the U-shape member, the under part of the U-shape member being fastened to the board frame and an intermediate part of both prongs of the U-shape member being fastened to a waist plate fixed on the board frame.

Abstract: Compositions and kits comprising combinations of ?-glucans and specific immunoglobulins are disclosed. The compositions and kits are useful in methods of preventing or treating infection by a pathogenic microorganism, in which ?-glucan is administered to a subject, and specific antibodies to a pathogenic microorganism are introduced into the subject.

Abstract: A vehicle frame includes a load carrying framework and a body mounted on the framework, said framework comprising a board frame, a window frame for windscreen, a pair of upper balks and a pair of upper window balks along both sides of the vehicle and supported at least by door pillars. Said window frame comprises a one piece U shaped member arranged between the board frame and the pair of upper balks, and an upper cross member connected to prongs of the U-shape member, the under part of said U-shape member being fastened to the board frame and an intermediate part of both prongs of the U-shape member being fastened to a waist plate fixed on the board frame.

Abstract: The invention relates to a transmission suspension structure for a rear engine vehicle, mainly bus, where the drive engine (3) and the gearbox (4) are built uniaxially to form a rigid transmission unit (2), which has suspension brackets (8, 9) in front and behind the center of gravity of the unit (2), in respect of the geometric axis of rotation of its main axis, the suspension bracket(s) (9) behind the center of gravity is (are) adjoined to the gearbox (4), a further two suspension brackets (8) are adjoined to the lower ends (23) of the two suspension bars (20) holding the transmission, and at the upper ends of the said suspension bars there are flexible adjoining members (21) for linkage to the body of the bus in the vicinity of its right hand side and left hand side walls.

Abstract: A negatively-charged Staphylococcus antigen contains amino acids and a N-acetylated hexosamine as a major carbohydrate component. The antigen is common to many coagulase-negative strains of Staphylococcus, including S. epidermidis, S. haemolyticus, and S. hominis. Staphylococcus strains that carry the antigen include many clinically significant strains of Staphylococcus. The antigen and antibodies to the antigen are useful in kits and assays for diagnosing Staphylococcus infection. Vaccines of the antigen and of whole cells that carry the antigen also are disclosed.